Access company data including market activity, funding rounds, last funding round price-per-share and valuation milestones. Use proprietary Forge Price data to track performance and monitor how company value changes over time.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| Cullgen | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $116M | Series C | 5/8/2023 | $35M | $264.09M | $2.63 | AstraZeneca-CICCVentureCapitalPartnership, SincereCapital, VoyagersCapital, WuxiCapitalGroup, GHIGroup | |||||
| DebtBook | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $24.1M | Series A-1 | 8/2/2023 | $12.5M | $282.51M | $12.86 | Elephant Partners, Meeting Street Capital, CreativeCo, Charlotte Fund | |||||
| Dispatch Biotherapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $179.79M | Series A | 7/23/2025 | $114M | $270.29M | $3.04 | ARCH Venture Partners, PICI, Bristol Myers Squibb, University of Pennsylvania, Stanford University, Alexandria Venture Investments | |||||
| Dream Labs | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $90.08M | Series Seed-1 | 6/30/2026 | $85.69M | $387.75M | $29.22 | 500 Global | |||||
| Eagle Wireless | Industrial Industrial Equipment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $44.63M | Series B | 2/19/2026 | $30M | $241.16M | $62.64 | The O.H.I.O. Fund, Asymmetric Capital Partners | |||||
| Element Science | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $115.4M | Series C-3 | 3/3/2020 | $163.35 | $296.95M | $1.63 | Deerfield Healthcare, Qiming Venture Partners, Cormorant Asset Management, Invus Opportunities, Third Rock Ventures, GV | |||||
| Eligible | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $4.36M | Series Seed | 1/13/2015 | $4.36M | $20.68M | $1.41 | Y Combinator, Deerfield Management, RTA Capital, MetaLab | |||||
| Ensoma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $250.75M | Series B-1 | 9/22/2025 | $45.2M | $281.79M | $1.09 | Gilead, 5AM Ventures, Catalio Capital Management, Cormorant Asset Management, Delos Capital, F-Prime Capital, Gates Foundation, Hanwha Impact Partners, Mirae Asset Financial Group, Qatar Investment Authority, RTW, Solasta Ventures, SymBiosis, Viking Global Investors | |||||
| Exactera | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119.65M | Series A | 7/17/2023 | $119.65M | $143.97M | $3.86 | Kennet Partners, Insight Venture Partners, Savant Growth Partners | |||||
| Foresight | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $144.31M | Series D | 1/30/2025 | $25M | $35.83M | $0.24 | Undisclosed Investors | |||||
| Forma | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $85.08M | Series C | 4/17/2023 | $35.05M | $233.88M | $3.38 | Undisclosed Investors | |||||
| Graphite | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $74.5M | Series B-1 | 3/17/2025 | $46.81M | $326.04M | $15.14 | Accel, Anthology Fund, Shopify Ventures, Figma Ventures, Andreessen Horowitz, The General Partnership | |||||
| GRIN Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $276.16M | Series D | 5/27/2025 | $140M | $439.01M | $1.79 | Angelini Pharma, Blackstone Life Sciences | |||||
| Injective Protocol | Fintech Blockchain | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $500,000.00 | Series Seed | 7/29/2020 | $500,000.00 | $5M | $1.80 | Pantera Capital, QCP Soteria, Axia8 Ventures, Boxone Ventures, Bitlink Capital | |||||
| Joy | Consumer & Lifestyle Consumer Applications | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119.51M | Series B-1 | 3/20/2026 | $15.6M | $373.51M | $4.78 | Undisclosed Investors | |||||
| Kasa Living | Consumer & Lifestyle Travel & Hospitality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $134.47M | Series C-Voting | 10/31/2023 | $64.04M | $284.92M | $6.60 | FJ Labs, Citi Ventures, FirstMark Capital, New York Life Ventures, Fireside Investments, RET Ventures, Zigg Capital, Ribbit Capital | |||||
| Kiddom | Education Other Education | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $71.94M | Series C | 8/13/2021 | $35M | $276.68M | $8.41 | Altos Ventures, Owl Ventures, Khosla Ventures, Outcomes Collective | |||||
| Kyte | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $203.9M | Series C-1 | 10/7/2024 | $29.92M | $94.5M | $0.61 | Undisclosed Investors | |||||
| LeanTaaS | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $214.7M | Series D-2 | 12/10/2020 | $99.66M | $491.79M | $12.72 | Insight Venture Partners, Goldman Sachs | |||||
| Luna | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $155.17M | Series C-1 | 6/30/2026 | $59.16M | $144.21M | $0.41 | Undisclosed Investors | |||||
| M.M.LaFleur | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $8.95M | Series A-1 | 12/16/2025 | $5M | $38.86M | $0.24 | Undisclosed Investors | |||||
| Matterport | Industrial Augmented / Virtual Reality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $144.15M | Series D | 4/29/2020 | $86.21M | $439.01M | $8.31 | Lux Capital, DCM Ventures, Qualcomm Ventures, Rev1 Ventures, Prairie Management Group, Plug and Play Tech Center, CBRE Group, BoxGroup, iRobot Ventures | |||||
| Maxwell | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $426.27M | Series B-2 | 10/2/2024 | $102.69M | $385.46M | $5.68 | Undisclosed Investors | |||||
| Medium | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.02M | Series A Prime | 4/30/2024 | $52.02M | $95.29M | $0.40 | Undisclosed Investors | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.